Private Equity Portfolio News: CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
SUNNYVALE, CA—Oct. 10, 2024—PRNewswire—CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, announced today the pricing…